We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Interim Analysis Suggests SARS-CoV-2 Vaccine Has 90% Efficacy Rate

News   Nov 09, 2020

 
Interim Analysis Suggests SARS-CoV-2 Vaccine Has 90% Efficacy Rate
 
 
Advertisement
 

RELATED ARTICLES

Key Questions and Answers About the UK's First Approved COVID-19 Vaccine

News

The UK government has announced that the COVID-19 vaccine BNT162b2 – developed by Pfizer and BioNTech – has been authorized for use. Here, we address some of the key questions you may have about this announcement.

READ MORE

Metabolic State of a Parasite Influences Its Resistance to Drugs

News

A new study has established that the parasite that causes chagas disease can be influenced by azole drugs, depending on its own metabolic state.

READ MORE

Drug Reverses Age-Related Mental Decline Within Days in Mouse Model

News

An experimental drug called ISRIB has been shown to reverse age-related declines in memory and mental flexibility in mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE